Usefulness of the epithelial tumor marker CA-125 in non-Hodgkin's lymphoma

被引：23

作者：

Özgüroglu, M ^{[1
]}

Turna, H ^{[1
]}

Demir, G ^{[1
]}

Döventas, A ^{[1
]}

Demirelli, F ^{[1
]}

Mandel, NM ^{[1
]}

Büyükünal, E ^{[1
]}

Serdengeçti, S ^{[1
]}

Berkarda, B ^{[1
]}

机构：

[1] Istanbul Univ, Cerrahpasa Med Sch, Dept Internal Med, Sect Med Oncol, Istanbul, Turkey

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1999年 / 22卷 / 06期

关键词：

non-Hodgkin's lymphoma; CA-125; staging; LDH; beta; 2-microglobulin;

D O I：

10.1097/00000421-199912000-00014

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CA-125: a commonly used tumor marker for epithelial ovarian cancer, Is a glycoprotein found in normal tissues derived from coelomic epithelia. Increased serum levels of CA-125 have also been found in nongynecologic tumors and nonmalignant diseases involving the peritoneum. A few recent studies and sporadic case reports have reported increased CA-125 levels in patients with non-Hodgkin's lymphoma (NHL). In our study, we aimed to evaluate the serum levels of CA-125 in patients with NHL and determine its potential role to show disease activity in NHL. Serum levels of CA-125 were measured in 61 patients with NHL and were found to be correlated with clinical stage, site of involvement, and disease activity.

引用

页码：615 / 618

页数：4

共 22 条

[1]

APEL RL, 1995, ARCH PATHOL LAB MED, V119, P373

[2] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].

BAST, RC ;

KLUG, TL ;

STJOHN, E ;

JENISON, E ;

NILOFF, JM ;

LAZARUS, H ;

BERKOWITZ, RS ;

LEAVITT, T ;

GRIFFITHS, CT ;

PARKER, L ;

ZURAWSKI, VR ;

KNAPP, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887

[3]

BERGMANN JF, 1987, CANCER-AM CANCER SOC, V59, P213, DOI 10.1002/1097-0142(19870115)59:2<213::AID-CNCR2820590206>3.0.CO

[4]

2-I

[5] WHAT DO WE KNOW ABOUT THE ORIGIN OF CA-125 [J].

BISCHOF, P .

EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 49 (1-2) :93-98

[6]

BRUIJN HW, 1997, CURR OPIN OBSTET GYN, V9, P8

[7]

Buller RE, 1996, AM J OBSTET GYNECOL, V174, P1241, DOI 10.1016/S0002-9378(96)70667-1

[8]

CANDOCIA SA, 1993, CANCER, V72, P2016, DOI 10.1002/1097-0142(19930915)72:6<2016::AID-CNCR2820720637>3.0.CO

[9]

2-T

[10] OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER [J].

CANNEY, PA ;

MOORE, M ;

WILKINSON, PM ;

JAMES, RD .

BRITISH JOURNAL OF CANCER, 1984, 50 (06) :765-769

← 1 2 3 →